Concepedia

Agustin Vega-Crespo

AV

13

Publications

1.3K

Citations

13

H-Index

2013

Active since

Affiliations

University of California, Los Angeles(Current)

Parker Institute for Cancer Immunotherapy

UCLA Medical Center

University of Lausanne

UCLA Health

Agustin Vega-Crespo is an author at University of California, Los Angeles specializing in immunotherapy, immunology, and medicine.

ORCID

Top concepts

Publications per year

2013–2024

13

Publications

13

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko et al. · Cancer Cell · 2020 · 361 citations · Full text

, , +7

Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy

Cristina Puig-Saus, Barbara Sennino, Songming Peng et al. · Nature · 2023 · 188 citations · Full text

, , +5

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

Ari M. Vanderwalde, Shay Bellasea, Kari Kendra et al. · Nature Medicine · 2023 · 150 citations · Full text

, , +8

Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade

Davis Y. Torrejon, Gabriel Abril-Rodríguez, Ameya S. Champhekar et al. · Cancer Discovery · 2020 · 137 citations · Full text

Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

Anusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi et al. · Science Translational Medicine · 2020 · 123 citations · Full text

Rows per page

1–5 of 13